Dorsey Wright & Associates’s Idexx Laboratories IDXX Stock Holding History

Dorsey Wright & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,577	Closed	-$2.42M	–	168
2025 Q4	$2.42M	Sell	3,577 -24	-0.7%	-$16.3K	0.52%	64
2025 Q3	$2.3M	Buy	+3,601	New	+$2.19M	0.51%	63
2021 Q2	–	Sell	-4,457	Closed	-$2.18K	–	326
2021 Q1	$2.18K	Sell	4,457 -209	-4%	-$105K	0.03%	246
2020 Q4	$2.33M	Buy	+4,666	New	+$2.09M	0.34%	87
2020 Q3	–	Sell	-2,953	Closed	-$988K	–	333
2020 Q2	$988K	Buy	+2,953	New	+$855K	0.2%	125
2018 Q4	–	Sell	-17	Closed	-$4K	–	309
2018 Q3	$4K	Buy	+17	New	+$4.13K	﹤0.01%	281
2018 Q1	–	Sell	-16,920	Closed	-$2.65M	–	130
2017 Q4	$2.65M	Sell	16,920 -6,951	-29%	-$1.09M	0.48%	74
2017 Q3	$3.71M	Buy	23,871 +2,304	+11%	+$364K	0.86%	60
2017 Q2	$3.48M	Buy	21,567 +2,456	+13%	+$399K	1.07%	29
2017 Q1	$2.96M	Buy	+19,111	New	+$2.63M	1.01%	26

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dorsey Wright & Associates's IDXX Position: Q1 2026 in Review

Dorsey Wright & Associates sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 3,577 shares — an estimated $2.42M sold.

Dorsey Wright & Associates first reported a position in IDXX in Q1 2017 and held it in 10 quarters. The position peaked at $3.71M in Q3 2017. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Dorsey Wright & Associates reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Dorsey Wright & Associates sold 3,577 Idexx Laboratories shares in Q1 2026, an estimated $2.42M.
Dorsey Wright & Associates first reported a position in Idexx Laboratories in Q1 2017 and held it in 10 quarters.
Dorsey Wright & Associates's Idexx Laboratories position peaked at $3.71M in Q3 2017.
1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Dorsey Wright & Associates's 13F filing for Q1 2026, filed 6 May 2026.